The Irish government, through its Industrial DevelopmentAgency, has invested $840,000 in Trinity Biotech plc through aprivate placement of restricted common stock, the Dublincompany announced. The government will invest $380,000immediately, with the balance to be invested in three partsover the next 18 months.
Trinity Biotech's (NASDAQ:HIVSY) diagnostics business isfocused on developing rapid, on-site saliva tests for HIV andother infectious diseases.
(c) 1997 American Health Consultants. All rights reserved.